Kangmei Pharmaceutical Co., Ltd.

¥1.34As of Sun 8 Nov 2026, 12:00 UTC
SSE:600518Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (22.18%)
Div yield —
ROE 1.27%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.58
PE TTM 236.7
TSR TTM (34.95%)
Mkt cap ¥18.53B
ROIC (3.21%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥1.73
29.21%
104.85%
Hold 8|6|7|1|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.01
0.01
0.01
0.01
2.87%
(3.14%)
4.96%
8.85%
Revenue¥M
880.1
910.7
947.8
981.6
0.75%
6.02%
7.34%
9.97%
Peers (US$2.778B)
Cap (US$)
PE
2.777B
—
Capital
TTM
5Y
10Y
Leveragex
0.678
0.057
0.047
EBIT/Intx
0.244
0.142
0.142
Own earn%
99.15
(131.65)
(124.58)
Sh yield%
39.80
38.89
36.81
Owners
Insiders/Inst%
3.80
74.53
Short interest%
3.96
SBC / revenue%
1.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
0–7
$1 testx
—
Incr. ROIC%
12